Search results
Results from the WOW.Com Content Network
Levetiracetam, sold under the brand name Keppra among others, is a novel antiepileptic drug [7] used to treat epilepsy. [8] It is used for partial-onset , myoclonic , or tonic–clonic seizures, [ 7 ] and is taken either by mouth as an immediate or extended release formulation or by injection into a vein .
[52] [53] [54] As of July 2021, a large number of drugs had been considered for treating COVID-19 patients. [55] As of November 2022, there was moderate-certainty evidence suggesting that dexamethasone, and systemic corticosteroids in general, probably cause a slight reduction in all-cause mortality (up to 30 days) in hospitalized patients with ...
The most common adverse effects of brivaracetam therapy include sedation, fatigue, dizziness, and nausea. [20] The FDA-approved drug label for brivaracetam states that patients who are CYPC19 poor metabolizers, or are taking medicines that inhibit CYP2C19, may require a dose reduction.
In the original clinical trials for Pfizer-BioNTech's COVID-19 vaccine, for example, less than half of study participants reported side effects, but the shot worked well for the vast majority of ...
The updated COVID-19 vaccine is now available. Infectious disease doctors recommend being smart about the timing of your shot. You can expect similar side effects to the previous vaccines if you ...
This category contains those articles about the side effects of medications. Some side effects are not adverse. For example, the anti-depressant Welbutrin helps some to quit smoking. Other beneficial side effects of medications can be weight loss. A side effect of insulin is that it removes potassium ions from the blood stream and into cells.
With a potential government shutdown looming ahead of the holidays, here's what you need to know if mail services will be impacted by it.
These side effects are serious and some of them are permanent, and many remain a crucial concern for companies and healthcare professionals and substantial efforts are being encouraged to reduce the potential risks for future antipsychotics through more clinical trials and drug development.